Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Jai Radhe Sales is your partner for all your sourcing needs.
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
27
PharmaCompass offers a list of Xylazine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Xylazine Hydrochloride manufacturer or Xylazine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Xylazine Hydrochloride manufacturer or Xylazine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Xylazine Hydrochloride API Price utilized in the formulation of products. Xylazine Hydrochloride API Price is not always fixed or binding as the Xylazine Hydrochloride Price is obtained through a variety of data sources. The Xylazine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Xylazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Xylazine, including repackagers and relabelers. The FDA regulates Xylazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Xylazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Xylazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Xylazine supplier is an individual or a company that provides Xylazine active pharmaceutical ingredient (API) or Xylazine finished formulations upon request. The Xylazine suppliers may include Xylazine API manufacturers, exporters, distributors and traders.
click here to find a list of Xylazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Xylazine DMF (Drug Master File) is a document detailing the whole manufacturing process of Xylazine active pharmaceutical ingredient (API) in detail. Different forms of Xylazine DMFs exist exist since differing nations have different regulations, such as Xylazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Xylazine DMF submitted to regulatory agencies in the US is known as a USDMF. Xylazine USDMF includes data on Xylazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Xylazine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Xylazine suppliers with USDMF on PharmaCompass.
A Xylazine CEP of the European Pharmacopoeia monograph is often referred to as a Xylazine Certificate of Suitability (COS). The purpose of a Xylazine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Xylazine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Xylazine to their clients by showing that a Xylazine CEP has been issued for it. The manufacturer submits a Xylazine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Xylazine CEP holder for the record. Additionally, the data presented in the Xylazine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Xylazine DMF.
A Xylazine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Xylazine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Xylazine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Xylazine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Xylazine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Xylazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Xylazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Xylazine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Xylazine suppliers with NDC on PharmaCompass.
Xylazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Xylazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Xylazine GMP manufacturer or Xylazine GMP API supplier for your needs.
A Xylazine CoA (Certificate of Analysis) is a formal document that attests to Xylazine's compliance with Xylazine specifications and serves as a tool for batch-level quality control.
Xylazine CoA mostly includes findings from lab analyses of a specific batch. For each Xylazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Xylazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Xylazine EP), Xylazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Xylazine USP).
